Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shironjit Saha

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|December 1, 2007
Eosinophilic airway inflammation in COPDShironjit Saha, Christopher E Brightling
Thorax|November 2, 2010
Risk disclosure prior to bronchoscopyStephen M Bianchi, Shironjit Saha, Paul Anderson
Pharmacoeconomics|September 22, 2017
Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology AppraisalIñigo Bermejo, Matt Stevenson, Katy Cooper, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
International Journal of Chronic Obstructive Pulmonary Disease|December 1, 2007
Eosinophilic airway inflammation in COPDShironjit Saha, Christopher E Brightling
Thorax|November 2, 2010
Risk disclosure prior to bronchoscopyStephen M Bianchi, Shironjit Saha, Paul Anderson
Pharmacoeconomics|September 22, 2017
Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology AppraisalIñigo Bermejo, Matt Stevenson, Katy Cooper, et al.
Pageof 1